Paul Tudor Jones Sera Prognostics, Inc. Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.2 - $3.62 $41,778 - $126,030	-34,815 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.96 - $8.8 $296 - $880	-100 Reduced 0.29%	34,815 $132,000
Q4 2021 Feb 14, 2022	SELL	$6.87 - $11.41 $208,985 - $347,092	-30,420 Reduced 46.56%	34,915 $240,000
Q3 2021 Nov 15, 2021	BUY	$7.9 - $13.04 $516,146 - $851,968	65,335 New	65,335 $726,000

19M

35.4K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $229M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.